$97 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$141.02 - $210.10The lowest and highst price in the last 52 weeks.
50.82xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.95 (0.46%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$97 Billion|
|Enterprise Value||$101 Billion|
|Dividend Yield||$0.95 (0.46%)|
|1 Year Return||+29.5%|
|Outstanding Shares||474 Million|
|Avg 30 Day Volume||1.38 Million|
|Earnings per Share||$3.99|
|Price to Sales Ratio||14.62|
|Price to Book Ratio||22.75|
|Revenue to Enterprise Value||14.34|
|EBIT to Enterprise Value||40.27|
|Total Debt to Enterprise Value||0.07|
|Debt to Equity||1.65|
|Gross Profit||$4.87 Billion|
|Net Income||$1.77 Billion|
|Quarterly Earnings Growth (YoY)||+32.2%|
|Return on Equity||40.78%|
|Return on Assets||12.61%|
|Return on Invested Capital||20.85%|
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees.
Top Players Covered in the Veterinary Vaccines Market Research Report are Elanco (Greenfield, U.S.), HIPRA (Girona, Spain), Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany), Vi...Intrado Digital Media, 3 days ago
Tim Bettington is Executive Vice President and President, U.S. Operations and Global Customer Experience with Zoetis. It could take up to three more years to develop an active solution, Bettington ...Brownfield Ag News, 4 days ago
The BRD Treatment Market provides analysis and insights relating to the many factors expected to be rife throughout the forecast amount whereas providing their impacts on the Markets growth. The in...OpenPR, 4 days ago